GlassScriptPhysician profile
Ashley Scott Brewer
NPI 1417086547
$1,846.76
in general payments reported to CMS, 2019-2025
27 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Addiction Medicine (Family Medicine) provider received nationally (typical 2025 total: $143).
See the full distribution for Addiction Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $26.10 · 2021: $209 · 2022: $319 · 2023: $532 · 2024: $255 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $244.94 | 2022-2025 | Xifaxan |
| Abbvie INC. | $219.70 | 2022-2025 | Vraylar, Dalvance, Teflaro |
| Indivior INC. | $194.88 | 2020-2024 | Sublocade |
| Novartis Pharmaceuticals Corporation | $154.55 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $123.62 | 2019-2023 | Xarelto |
| La Jolla Pharmaceutical Company | $121.20 | 2021-2023 | Xerava |
| Pfizer INC. | $101.82 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.75 | 2019-2024 | Jardiance |
| Smith+Nephew, INC. | $85.44 | 2019-2025 | Collagenase Santyl |
| E.R. Squibb & Sons, L.L.C. | $64.15 | 2021-2022 | |
| Genzyme Corporation | $61.47 | 2025 | |
| Braeburn INC. | $51.07 | 2023 | Brixadi |
| Merck Sharp & Dohme LLC | $50.40 | 2019-2023 | Zerbaxa, Dificid |
| Boston Scientific Corporation | $38.07 | 2023-2024 | Watchman Flx |
| Otsuka America Pharmaceutical, INC. | $33.05 | 2025 | Jynarque |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $28.55 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Advanced Oxygen Therapy INC. | $23.92 | 2025 | Topical Oxygen Chamber For Extremities |
| Paratek Pharmaceuticals, INC. | $22.96 | 2025 | Nuzyra |
| Novo Nordisk INC | $18.82 | 2023 | |
| Exact Sciences Corporation | $17.91 | 2025 | Cologuard Collection Kit |
| Enterra Medical, INC. | $15.63 | 2023 | |
| Irhythm Technologies, INC. | $15.02 | 2019 | |
| Mimedx Group, INC. | $14.01 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $13.55 | 2021 | |
| Alkermes, INC. | $12.25 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.82 | 2021 | |
| Portola Pharmaceuticals, LLC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Brewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.